In one study, participants treated with semaglutide lost an average of 15.3% of their body weight over 68 weeks, compared to 2.6% in the placebo group
This creates an odd incentive structure
Abrupt discontinuation of a medicine controlling glucose levels could lead to poorly managed diabetes which can adversely affect your health and the health of your baby
Most adverse events were mild to moderate GI symptoms, consistent with the known class effects of GLP-1based agents. Jastreboff et al., NEJM Additional Observations Some participants experienced a mild increase in resting heart rate similar to other GLP-1 drugs No serious hypoglycemia was observed unless combined with insulin or sulfonylureas A small number reported transient increases in liver enzymes , which normalized No increase in gallbladder events or pancreatitis noted compared to placebo Overall discontinuation rates were low (under 10%) How to Support Tolerance Naturally Stacking Retatrutide (once approved) with lifestyle and supplement support may enhance tolerability: Use Krill Oil to combat inflammation and improve lipid profiles Support gut health with Probiotics to reduce GI discomfort Ensure adequate hydration and electrolytes via INTRA during training or fasted cardio While Retatrutide is still investigational, early trials suggest its no more difficult to tolerate than Semaglutide or Tirzepatide and for many, the results may far outweigh the adjustment phase
Duelund-Jakobsen J, Buntzen S, Lundby L, Laurberg S
